Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone

Authors:
  • NZN. Zamberlan
    N. Zamberlan
  • MMM. Mian
    M. Mian
  • RDR. Dorizzi
    R. Dorizzi
  • BBB. Braga
    B. Braga
  • DGD. Gatti
    D. Gatti
  • FBF. Bertoldo
    F. Bertoldo
  • VLV. Locascio
    V. Locascio

Abstract
No abstract available

This publication has 11 references indexed in Scilit: